Coloma Jason V
SEC CIK 1676170 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | CEO, Dir | 27.4K | — | $5.25M | 9 | 2026-05-15 | 2026-09-02 |
Most active insiders at MAZE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bernstein Harold | Pres, CMO, R, D | — | $9.02M |
| 2 | Coloma Jason V | CEO, Dir | — | $5.25M |
| 3 | Dandekar Atul | CSBO | — | $5.01M |
| 4 | Bachrodt Amy | SVP, Fin | — | $1.56M |
| 5 | Sohn Catherine A. | Dir | — | $1.15M |
| 6 | Courtney Phillips | GC, Corp. Sec | — | $104.8K |
| 7 | Third Rock Ventures GP V, LP | 10% | — | — |
| 8 | HOMCY CHARLES J | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-04 16:24 | 2026-09-02+ | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.24 | -22.6K | 27.4K | -45% | -$594.0K |
| DMTI | 2026-09-03 16:27 | 2026-09-01 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale+OE | $26.29 | -34.5K | 223.4K | -13% | -$907.0K |
| DT | 2026-09-03 16:27 | 2026-09-01 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | M - OptEx | $0.00 | +50.0K | 50.0K | New | $0 |
| MTI | 2026-08-05 16:08 | 2026-08-03 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.73 | -34.5K | 255.3K | -12% | -$922.3K |
| MTI | 2026-07-02 16:28 | 2026-07-01 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $29.98 | -34.5K | 287.2K | -11% | -$1.03M |
| MTI | 2026-06-24 16:14 | 2026-06-22+ | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.04 | -27.9K | 319.1K | -8% | -$725.5K |
| MTI | 2026-06-03 17:04 | 2026-06-01 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.20 | -6,643 | 28.0K | -19% | -$174.0K |
| MTI | 2026-05-27 16:16 | 2026-05-22+ | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.01 | -32.6K | 351.0K | -8% | -$847.0K |
| MTI | 2026-05-18 17:07 | 2026-05-15 | MAZE | Maze Therapeutics, Inc. | Coloma Jason V | CEO, Dir | S - Sale | $26.00 | -1,938 | 31.0K | -6% | -$50.4K |
Purchase Sale Sale after option exercise All abbreviations